{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:50:07Z","timestamp":1791978607972,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7390","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/nature10882","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T17:09:26Z","timestamp":1331312966000},"page":"489-493","source":"Crossref","is-referenced-by-count":111,"title":["Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4\u2009\u00c5"],"prefix":"10.1038","volume":"483","author":[{"given":"Zachary Lee","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheom-Gil","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,11]]},"reference":[{"key":"BFnature10882_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tips.2006.06.004","volume":"27","author":"AE King","year":"2006","unstructured":"King, A. E., Ackley, M. A., Cass, C. E., Young, J. D. & Baldwin, S. A. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol. Sci. 27, 416\u2013425 (2006)","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnature10882_CR2","first-page":"41","volume":"23","author":"JB Rose","year":"2008","unstructured":"Rose, J. B. & Coe, I. R. Physiology of nucleoside transporters: back to the future. Physiology (Bethesda) 23, 41\u201348 (2008)","journal-title":"Physiology (Bethesda)"},{"key":"BFnature10882_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bcp.2007.10.005","volume":"75","author":"P Cano-Soldado","year":"2008","unstructured":"Cano-Soldado, P. et al. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells. Biochem. Pharmacol. 75, 639\u2013648 (2008)","journal-title":"Biochem. Pharmacol."},{"key":"BFnature10882_CR4","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1038\/sj.onc.1206952","volume":"22","author":"VL Damaraju","year":"2003","unstructured":"Damaraju, V. L. et al. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy. Oncogene 22, 7524\u20137536 (2003)","journal-title":"Oncogene"},{"key":"BFnature10882_CR5","first-page":"138","volume":"1776","author":"LP Jordheim","year":"2007","unstructured":"Jordheim, L. P. & Dumontet, C. Review of recent studies on resistance to cytotoxic deoxynucleoside analogues. Biochim. Biophys. Acta 1776, 138\u2013159 (2007)","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnature10882_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/pgs.10.70","volume":"11","author":"E Errasti-Murugarren","year":"2010","unstructured":"Errasti-Murugarren, E. & Pastor-Anglada, M. Drug transporter pharmacogenetics in nucleoside-based therapies. Pharmacogenomics 11, 809\u2013841 (2010)","journal-title":"Pharmacogenomics"},{"key":"BFnature10882_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1368-7646(98)80047-2","volume":"1","author":"JR Mackey","year":"1998","unstructured":"Mackey, J. R., Baldwin, S. A., Young, J. D. & Cass, C. E. Nucleoside transport and its significance for anticancer drug resistance. Drug Resist. Updat. 1, 310\u2013324 (1998)","journal-title":"Drug Resist. Updat."},{"key":"BFnature10882_CR8","first-page":"110","volume":"8","author":"JR Mackey","year":"2002","unstructured":"Mackey, J. R. et al. Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin. Cancer Res. 8, 110\u2013116 (2002)","journal-title":"Clin. Cancer Res."},{"key":"BFnature10882_CR9","first-page":"4349","volume":"58","author":"JR Mackey","year":"1998","unstructured":"Mackey, J. R. et al. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. 58, 4349\u20134357 (1998)","journal-title":"Cancer Res."},{"key":"BFnature10882_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00280-004-0861-7","volume":"55","author":"K Nagai","year":"2005","unstructured":"Nagai, K., Nagasawa, K. & Fujimoto, S. Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system. Cancer Chemother. Pharmacol. 55, 222\u2013230 (2005)","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnature10882_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0165-6147(98)01253-X","volume":"19","author":"M Pastor-Anglada","year":"1998","unstructured":"Pastor-Anglada, M., Felipe, A. & Casado, F. J. Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. Trends Pharmacol. Sci. 19, 424\u2013430 (1998)","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnature10882_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/sj.leu.2403271","volume":"18","author":"M Pastor-Anglada","year":"2004","unstructured":"Pastor-Anglada, M. et al. Nucleoside transporters in chronic lymphocytic leukaemia. Leukemia 18, 385\u2013393 (2004)","journal-title":"Leukemia"},{"key":"BFnature10882_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","volume":"26","author":"J Zhang","year":"2007","unstructured":"Zhang, J. et al. The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs. Cancer Metastasis Rev. 26, 85\u2013110 (2007)","journal-title":"Cancer Metastasis Rev."},{"key":"BFnature10882_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00424-003-1107-y","volume":"447","author":"JH Gray","year":"2004","unstructured":"Gray, J. H., Owen, R. P. & Giacomini, K. M. The concentrative nucleoside transporter family, SLC28. Pflugers Arch. 447, 728\u2013734 (2004)","journal-title":"Pflugers Arch."},{"key":"BFnature10882_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2174\/157016109789043892","volume":"7","author":"M Molina-Arcas","year":"2009","unstructured":"Molina-Arcas, M., Casado, F. J. & Pastor-Anglada, M. Nucleoside transporter proteins. Curr. Vasc. Pharmacol. 7, 426\u2013434 (2009)","journal-title":"Curr. Vasc. Pharmacol."},{"key":"BFnature10882_CR16","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1074\/jbc.M007746200","volume":"276","author":"MW Ritzel","year":"2001","unstructured":"Ritzel, M. W. et al. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J. Biol. Chem. 276, 2914\u20132927 (2001)","journal-title":"J. Biol. Chem."},{"key":"BFnature10882_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/yea.1000","volume":"20","author":"SK Loewen","year":"2003","unstructured":"Loewen, S. K. et al. Functional characterization of a H+\/nucleoside co-transporter (CaCNT) from Candida albicans, a fungal member of the concentrative nucleoside transporter (CNT) family of membrane proteins. Yeast 20, 661\u2013675 (2003)","journal-title":"Yeast"},{"key":"BFnature10882_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/0968768031000140836","volume":"21","author":"SK Loewen","year":"2004","unstructured":"Loewen, S. K. et al. Transport of physiological nucleosides and anti-viral and anti-neoplastic nucleoside drugs by recombinant Escherichia coli nucleoside-H+ cotransporter (NupC) produced in Xenopus laevis oocytes. Mol. Membr. Biol. 21, 1\u201310 (2004)","journal-title":"Mol. Membr. Biol."},{"key":"BFnature10882_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1124\/mol.59.2.339","volume":"59","author":"G Xiao","year":"2001","unstructured":"Xiao, G., Wang, J., Tangen, T. & Giacomini, K. M. A novel proton-dependent nucleoside transporter, CeCNT3, from Caenorhabditis elegans. Mol. Pharmacol. 59, 339\u2013348 (2001)","journal-title":"Mol. Pharmacol."},{"key":"BFnature10882_CR20","doi-asserted-by":"publisher","first-page":"27981","DOI":"10.1074\/jbc.M100518200","volume":"276","author":"SR Hamilton","year":"2001","unstructured":"Hamilton, S. R. et al. Subcellular distribution and membrane topology of the mammalian concentrative Na+-nucleoside cotransporter rCNT1. J. Biol. Chem. 276, 27981\u201327988 (2001)","journal-title":"J. Biol. Chem."},{"key":"BFnature10882_CR21","doi-asserted-by":"publisher","first-page":"17281","DOI":"10.1074\/jbc.M109.009704","volume":"284","author":"MD Slugoski","year":"2009","unstructured":"Slugoski, M. D. et al. Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G\/A)XKX3NEFVA(Y\/M\/F). J. Biol. Chem. 284, 17281\u201317292 (2009)","journal-title":"J. Biol. Chem."},{"key":"BFnature10882_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1042\/BJ20051476","volume":"394","author":"J Zhang","year":"2006","unstructured":"Zhang, J. et al. Cysteine-accessibility analysis of transmembrane domains 11\u201313 of human concentrative nucleoside transporter 3. Biochem. J. 394, 389\u2013398 (2006)","journal-title":"Biochem. J."},{"key":"BFnature10882_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature09939","volume":"473","author":"Y Cao","year":"2011","unstructured":"Cao, Y. et al. Crystal structure of a phosphorylation-coupled saccharide transporter. Nature 473, 50\u201354 (2011)","journal-title":"Nature"},{"key":"BFnature10882_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nature03018","volume":"431","author":"D Yernool","year":"2004","unstructured":"Yernool, D., Boudker, O., Jin, Y. & Gouaux, E. Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature 431, 811\u2013818 (2004)","journal-title":"Nature"},{"key":"BFnature10882_CR25","doi-asserted-by":"publisher","first-page":"24475","DOI":"10.1074\/jbc.274.35.24475","volume":"274","author":"SK Loewen","year":"1999","unstructured":"Loewen, S. K. et al. Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concentrative Na+ nucleoside cotransporters hCNT1 and hCNT2. J. Biol. Chem. 274, 24475\u201324484 (1999)","journal-title":"J. Biol. Chem."},{"key":"BFnature10882_CR26","doi-asserted-by":"publisher","first-page":"17266","DOI":"10.1074\/jbc.M109.009613","volume":"284","author":"MD Slugoski","year":"2009","unstructured":"Slugoski, M. D. et al. Conserved glutamate residues Glu-343 and Glu-519 provide mechanistic insights into cation\/nucleoside cotransport by human concentrative nucleoside transporter hCNT3. J. Biol. Chem. 284, 17266\u201317280 (2009)","journal-title":"J. Biol. Chem."},{"key":"BFnature10882_CR27","doi-asserted-by":"publisher","first-page":"30607","DOI":"10.1074\/jbc.M703285200","volume":"282","author":"SY Yao","year":"2007","unstructured":"Yao, S. Y. et al. Conserved glutamate residues are critically involved in Na+\/nucleoside cotransport by human concentrative nucleoside transporter 1 (hCNT1). J. Biol. Chem. 282, 30607\u201330617 (2007)","journal-title":"J. Biol. Chem."},{"key":"BFnature10882_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1006\/jmbi.1996.0081","volume":"256","author":"M Nayal","year":"1996","unstructured":"Nayal, M. & Di Cera, E. Valence screening of water in protein crystals reveals potential Na+ binding sites. J. Mol. Biol. 256, 228\u2013234 (1996)","journal-title":"J. Mol. Biol."},{"key":"BFnature10882_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl\u2212-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005)","journal-title":"Nature"},{"key":"BFnature10882_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature08143","volume":"459","author":"H Krishnamurthy","year":"2009","unstructured":"Krishnamurthy, H., Piscitelli, C. L. & Gouaux, E. Unlocking the molecular secrets of sodium-coupled transporters. Nature 459, 347\u2013355 (2009)","journal-title":"Nature"},{"key":"BFnature10882_CR31","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/pro.193","volume":"18","author":"M Koszelak-Rosenblum","year":"2009","unstructured":"Koszelak-Rosenblum, M. et al. Determination and application of empirically derived detergent phase boundaries to effectively crystallize membrane proteins. Protein Sci. 18, 1828\u20131839 (2009)","journal-title":"Protein Sci."},{"key":"BFnature10882_CR32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997)","journal-title":"Methods Enzymol."},{"key":"BFnature10882_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S0108767307043930","volume":"64","author":"GM Sheldrick","year":"2008","unstructured":"Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. A 64, 112\u2013122 (2008)","journal-title":"Acta Crystallogr. A"},{"key":"BFnature10882_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1107\/S0907444999000839","volume":"55","author":"TC Terwilliger","year":"1999","unstructured":"Terwilliger, T. C. & Berendzen, J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55, 849\u2013861 (1999)","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnature10882_CR35","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1107\/S0907444900005072","volume":"56","author":"TC Terwilliger","year":"2000","unstructured":"Terwilliger, T. C. Maximum-likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 56, 965\u2013972 (2000)","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnature10882_CR36","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004)","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnature10882_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658\u2013674 (2007)","journal-title":"J. Appl. Cryst."},{"key":"BFnature10882_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010)","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnature10882_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jmb.2009.02.034","volume":"387","author":"SY Lee","year":"2009","unstructured":"Lee, S. Y., Letts, J. A. & MacKinnon, R. Functional reconstitution of purified human Hv1 H+ channels. J. Mol. Biol. 387, 1055\u20131060 (2009)","journal-title":"J. Mol. Biol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature10882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature10882","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature10882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:58:52Z","timestamp":1684432732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature10882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":39,"journal-issue":{"issue":"7390","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFnature10882"],"URL":"https:\/\/doi.org\/10.1038\/nature10882","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}